Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to Thermo Fisher Scientific for approximately USD 4 billion in cash, subject to customary adjustments, effective 1 September 2025.
The divested business is a leading global provider of purification and filtration technologies used in the production of biologics, as well as in medical technologies and industrial applications. It operates worldwide, with sites across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.
Paksoy is pleased to announce that a team led by partner Stéphanie Beghe Sönmez and associates Meriç Saçak Albaş and Cansın Taner acted as Turkish counsel to Solventum, alongside Cleary Gottlieb Steen & Hamilton, which served as global counsel on this multijurisdictional transaction.
Share
Related persons
You can contact us for detailed information.


Legal Information
This is for information purposes; it is not legal advice. As laws and their interpretation may change, please consult Turkish legal counsel to confirm the current position and obtain advice tailored to your circumstances before making any decision or taking action in relation to your matter in Türkiye. All rights reserved.
You May Be Interested In
19 October 2026
Merger clearance for Azimut’s acquisition of Yapı Kredi Portföy and landmark individual exemption for the 15-year distribution agreement
Two key Turkish Competition Board decisions were obtained in connection with Azimut’s acquisition of Yapı Kredi Portföy and the related…
15 October 2026
Mergermarket ranked us #1 in Türkiye by M&A deal value for 9M 2026
We are pleased to be recognised in the Mergermarket 2026-9M EMEA Legal Advisory Rankings, maintaining our #1 position by deal value in…
12 October 2026
Paksoy advises Turkven on its investment in Craftgate
On 8 October 2026, Turkven, one of the leading private equity firms focused on Türkiye, signed an agreement for the acquisition of shares…
6 October 2026
We celebrate 6 awards at the GBM Awards 2026
At the GBM Awards: CEE, Central Asia & Türkiye 2026, we celebrate 6 awards, recognising our strength in complex conventional and Islamic…
30 September 2026
Paksoy advises the Kocadağ Family on the sale of its 70% stake in Espressolab
On 23 September 2026, the Kocadağ Family entered into a share purchase agreement to sell their 70% stake in Espressolab, a leading local…
28 September 2026
Serdar Paksoy, has been named Türkiye Litigator of the Year at the Benchmark Litigation Europe Awards 2026
We are pleased to announce that our Founder & Senior Partner, Serdar Paksoy, has been named Türkiye Litigator of the Year at the Benchmark…
